These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34091824)

  • 1. Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.
    Heudel PE; Fervers B; Durand T; Chabaud S; Michallet AS; Gomez F; Rivoire M; Bachelot T; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Chvetzoff G; Pérol D; Blay JY
    Int J Clin Oncol; 2021 Oct; 26(10):1793-1804. PubMed ID: 34091824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary cancers in pediatric head and neck cancer survivors in Denmark during 1980-2014: A nationwide study.
    Schmidt Jensen J; Grønhøj C; Ruud Kjær EK; Charabi BW; von Buchwald C; Hjuler T
    Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109648. PubMed ID: 31472358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of second primary cancers in North Portugal-a population-based study.
    Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
    J Cancer Surviv; 2016 Feb; 10(1):142-52. PubMed ID: 26159159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis.
    Rubió-Casadevall J; Galceran J; Ameijide A; Puigdemont M; Llauradó L; Marruecos J; Izquierdo A; Carulla M; Borràs JL; Marcos-Gragera R; Gumà J
    Clin Transl Oncol; 2021 Apr; 23(4):788-798. PubMed ID: 32815088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal.
    Morais S; Antunes L; Bento MJ; Lunet N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):85-91. PubMed ID: 28843176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
    Adjei Boakye E; Wang M; Sharma A; Jenkins WD; Osazuwa-Peters N; Chen B; Lee M; Schootman M
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
    Heudel P; Chabaud S; Perol D; Flechon A; Fayette J; Combemale P; Tredan O; Desseigne F; de la Fouchardiere C; Boyle H; Perol M; Bachelot T; Cassier P; Avrillon V; Terret C; Michallet AS; Neidhardt-Berard EM; Nicolas-Virelizier E; Dufresne A; Belhabri A; Brahmi M; Lebras L; Nicolini F; Sarabi M; Rey P; Bonneville-Levard A; Rochefort P; Provensal AM; Eberst L; Assaad S; Swalduz A; Saintigny P; Toussaint P; Guillermin Y; Castets M; Coutzac C; Meeus P; Dupré A; Durand T; Crochet H; Fervers B; Gomez F; Rivoire M; Gregoire V; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Lasset C; Chvetzoff G; Mehlen P; Beaupère S; Zrounba P; Ray-Coquard I; Blay JY
    ESMO Open; 2021 Feb; 6(1):100044. PubMed ID: 33516148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.
    Guérin J; Nahid A; Tassy L; Deloger M; Bocquet F; Thézenas S; Desandes E; Le Deley MC; Durando X; Jaffré A; Es-Saad I; Crochet H; Le Morvan M; Lion F; Raimbourg J; Khay O; Craynest F; Giro A; Laizet Y; Bertaut A; Joly F; Livartowski A; Heudel P
    Int J Environ Res Public Health; 2024 Feb; 21(2):. PubMed ID: 38397680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.
    Neumann F; Jégu J; Mougin C; Prétet JL; Guizard AV; Lapôtre-Ledoux B; Bara S; Bouvier V; Colonna M; Troussard X; Trétarre B; Grosclaude P; Velten M; Woronoff AS
    Prev Med; 2016 Sep; 90():52-8. PubMed ID: 27370167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancer incidence and risk factors in patients with salivary gland cancers.
    Kwon M; Lee JI; Roh JL; Cho KJ; Choe J; Choi SH; Nam SY; Kim SY
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):118-23. PubMed ID: 24370632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide rates among patients with first and second primary cancer.
    Jiang Y; Wang Y; Cheng X; Zhou Z; Wang J; Yu H; Yao G; Lu Z; Chen X; Yan S; Zhao F
    Epidemiol Psychiatr Sci; 2023 Sep; 32():e57. PubMed ID: 37711033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort study.
    Ruan Z; Zhang Y; Li Z; Jiang J; Luo W; Quan Q; Xu Z; Lei J; Peng R
    Clin Exp Med; 2023 Dec; 23(8):5051-5062. PubMed ID: 37555912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
    Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
    Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
    Zheng G; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
    Cancer Med; 2020 Nov; 9(21):8258-8265. PubMed ID: 32960498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors.
    Moitry M; Velten M; Trétarre B; Bara S; Daubisse-Marliac L; Lapôtre-Ledoux B; Troussard X; Molinié F; Ligier K; Woronoff AS; Bouvier V; Colonna M; Klein D; Guizard AV; Jégu J
    Cancer Epidemiol; 2017 Apr; 47():35-41. PubMed ID: 28113110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
    Chuang SC; Scelo G; Tonita JM; Tamaro S; Jonasson JG; Kliewer EV; Hemminki K; Weiderpass E; Pukkala E; Tracey E; Friis S; Pompe-Kirn V; Brewster DH; Martos C; Chia KS; Boffetta P; Brennan P; Hashibe M
    Int J Cancer; 2008 Nov; 123(10):2390-6. PubMed ID: 18729183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.